Physician

Kazi S Khan, MD

According to 2025 Medicare claims, Kazi Khan, MD (NPI: 1063402857) practices nephrology in the Salisbury, MD market, with the plurality of this provider's patient population coming from Wicomico, MD. This provider's primary affiliated billing organization is PENINSULA NEPHROLOGY ASSOCIATES, PA (NPI: 1811916976; TIN: 521068452) and primary practice location at 21804-1664.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,314 traditional Medicare patients, billed 28,757 HCPCS/CPT codes, and received $1,289,369 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,736 prescription claims across 440 beneficiaries totaling $161,128 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2019 DME data shows 23 claims. Open Payments data shows 56 records totaling $1,237. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $440,879 to $1,289,369. Similarly, Part D prescription costs have moved sharply higher in recent years, from $43,988 to $161,128. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$930K$1.9M2015 Medicare payment: $440,879 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $514,992 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $457,151 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $477,717 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $400,972 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $497,577 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $779,718 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,859,581 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,580,978 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,289,369 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158745,005$440,879
20161,0914,864$514,992
20171,2215,090$457,151
20181,4216,238$477,717
20191,3147,007$400,972
20201,69210,096$497,577
20211,92812,162$779,718
20222,79527,243$1,859,581
20232,45227,674$1,580,978
20242,31428,757$1,289,369

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$131K$261K2015 Drug cost: $43,988 (USD; Tot_Drug_Cst)2016 Drug cost: $174,361 (USD; Tot_Drug_Cst)2017 Drug cost: $200,750 (USD; Tot_Drug_Cst)2018 Drug cost: $141,467 (USD; Tot_Drug_Cst)2019 Drug cost: $85,406 (USD; Tot_Drug_Cst)2020 Drug cost: $74,138 (USD; Tot_Drug_Cst)2021 Drug cost: $83,926 (USD; Tot_Drug_Cst)2022 Drug cost: $162,032 (USD; Tot_Drug_Cst)2023 Drug cost: $261,145 (USD; Tot_Drug_Cst)2024 Drug cost: $161,128 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015113477$43,988
20163151,111$174,361
20174021,745$200,750
20182511,084$141,467
2019232879$85,406
2020212740$74,138
2021227841$83,926
20223261,223$162,032
20234051,484$261,145
20244401,736$161,128

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$5.8K$12K2015 Medicare payment: $5,389 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $6,539 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $11,661 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $7,088 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $618 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R46$5,389
2016N/R86$6,539
201711209$11,661
2018N/R129$7,088
2019N/R23$618
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1,5372,988$83
99490Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month6965,933$43
99457Management using the results of remote vital sign monitoring per calendar month, first 20 minutes8405,753$34
99454Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days7394,612$33
99458Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes8294,762$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FarxigaDapagliflozin Propanediol301,950$32,602
KerendiaFinerenone171,110$23,550
JardianceEmpagliflozin331,180$22,529
Sevelamer CarbonateSevelamer Carbonate402,210$5,194
ProsolParenteral Amino Acid 20% No.129191$5,044

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.56$1,237AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kazi S. Khan, MD?

Tedicare shows public-source Medicare data for Kazi S. Khan, MD (NPI 1063402857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kazi S. Khan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kazi S. Khan, MD?

Kazi S. Khan, MD is linked to PENINSULA NEPHROLOGY ASSOCIATES, PA (billing NPI 1811916976) in the available physician profile data.

Does Kazi S. Khan, MD have Open Payments data?

Kazi S. Khan, MD has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.